Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 589

Cited In for PubMed (Select 15761121)

1.

Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population.

Chavali VR, Diniz B, Huang J, Ying GS, Sadda SR, Stambolian D.

J Clin Med. 2015;4(2):304-317.

2.

Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population.

Fang K, Gao P, Tian J, Qin X, Yu W, Li J, Chen Q, Huang L, Chen D, Hu Y, Li X.

J Ophthalmol. 2015;2015:821918. doi: 10.1155/2015/821918. Epub 2015 Mar 25.

3.

Role of tyrosine-sulfated proteins in retinal structure and function.

Kanan Y, Al-Ubaidi MR.

Exp Eye Res. 2015 Apr;133:126-31. doi: 10.1016/j.exer.2014.07.007. Review.

PMID:
25819460
4.

CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye.

Wang JC, Cao S, Wang A, To E, Law G, Gao J, Zhang D, Cui JZ, Matsubara JA.

Mol Vis. 2015 Mar 13;21:264-72. eCollection 2015.

5.

Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)-β Signaling in the Retinal Pigment Epithelium.

Li Y, Song D, Song Y, Zhao L, Wolkow N, Tobias JW, Song W, Dunaief JL.

J Biol Chem. 2015 May 8;290(19):11918-34. doi: 10.1074/jbc.M115.645903. Epub 2015 Mar 23.

PMID:
25802332
6.

Lens status influences the association between CFH polymorphisms and age-related macular degeneration: findings from two population-based studies in Singapore.

Wong CW, Liao J, Cheung GC, Khor CC, Vithana EN, Wang JJ, Mitchell P, Aung T, Wong TY, Cheng CY.

PLoS One. 2015 Mar 18;10(3):e0119570. doi: 10.1371/journal.pone.0119570. eCollection 2015.

8.

Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis.

Bertram P, Akk AM, Zhou HF, Mitchell LM, Pham CT, Hourcade DE.

Monoclon Antib Immunodiagn Immunother. 2015 Feb;34(1):1-6. doi: 10.1089/mab.2014.0066.

PMID:
25723276
9.

Activated complement classical pathway in a murine model of oxygen-induced retinopathy.

Tao XY, Zheng SJ, Lei B.

Int J Ophthalmol. 2015 Feb 18;8(1):17-22. doi: 10.3980/j.issn.2222-3959.2015.01.03. eCollection 2015.

10.

Inflammasomes Induced by 7-Ketocholesterol and Other Stimuli in RPE and in Bone Marrow-Derived Cells Differ Markedly in Their Production of IL-1β and IL-18.

Shi G, Chen S, Wandu WS, Ogbeifun O, Nugent LF, Maminishkis A, Hinshaw SJ, Rodriguez IR, Gery I.

Invest Ophthalmol Vis Sci. 2015 Feb 12;56(3):1658-64. doi: 10.1167/iovs.14-14557.

PMID:
25678688
11.

Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.

Mastellos DC, Yancopoulou D, Kokkinos P, Huber-Lang M, Hajishengallis G, Biglarnia AR, Lupu F, Nilsson B, Risitano AM, Ricklin D, Lambris JD.

Eur J Clin Invest. 2015 Apr;45(4):423-40. doi: 10.1111/eci.12419. Epub 2015 Mar 9.

PMID:
25678219
12.

Vision from next generation sequencing: Multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and disease.

Yang HJ, Ratnapriya R, Cogliati T, Kim JW, Swaroop A.

Prog Retin Eye Res. 2015 May;46:1-30. doi: 10.1016/j.preteyeres.2015.01.005. Epub 2015 Feb 7. Review.

13.

Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.

Schnabolk G, Coughlin B, Joseph K, Kunchithapautham K, Bandyopadhyay M, O'Quinn EC, Nowling T, Rohrer B.

Invest Ophthalmol Vis Sci. 2015 Jan 15;56(3):1850-63. doi: 10.1167/iovs.14-15910.

PMID:
25593023
14.

Mitochondrial variation and the risk of age-related macular degeneration across diverse populations.

Restrepo NA, Mitchell SL, Goodloe RJ, Murdock DG, Haines JL, Crawford DC.

Pac Symp Biocomput. 2015:243-54.

15.

Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease.

Gorin MB, Weeks DE, Baron RV, Conley YP, Ortube MC, Nusinowitz S.

J Clin Med. 2014 Nov 28;3(4):1335-1356.

16.

Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.

Petrou PA, Cunningham D, Shimel K, Harrington M, Hammel K, Cukras CA, Ferris FL, Chew EY, Wong WT.

Invest Ophthalmol Vis Sci. 2014 Dec 18;56(1):330-8. doi: 10.1167/iovs.14-15877.

PMID:
25525171
17.

Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Whitmore SS, Sohn EH, Chirco KR, Drack AV, Stone EM, Tucker BA, Mullins RF.

Prog Retin Eye Res. 2015 Mar;45:1-29. doi: 10.1016/j.preteyeres.2014.11.005. Epub 2014 Dec 5. Review.

PMID:
25486088
18.

Age-related macular degeneration: insights into inflammatory genes.

Cascella R, Ragazzo M, Strafella C, Missiroli F, Borgiani P, Angelucci F, Marsella LT, Cusumano A, Novelli G, Ricci F, Giardina E.

J Ophthalmol. 2014;2014:582842. doi: 10.1155/2014/582842. Epub 2014 Nov 12. Review.

19.

Expression of human complement factor h prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged cfh knockout mice.

Ding JD, Kelly U, Landowski M, Toomey CB, Groelle M, Miller C, Smith SG, Klingeborn M, Singhapricha T, Jiang H, Frank MM, Bowes Rickman C.

Am J Pathol. 2015 Jan;185(1):29-42. doi: 10.1016/j.ajpath.2014.08.026. Epub 2014 Nov 1.

PMID:
25447048
20.

Unbiased approaches to biomarker discovery in neurodegenerative diseases.

Chen-Plotkin AS.

Neuron. 2014 Nov 5;84(3):594-607. doi: 10.1016/j.neuron.2014.10.031. Epub 2014 Nov 5. Review.

PMID:
25442938
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk